AccolateTM Asthma Trialists Group: Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma - Spector,L.S.; Smith,L.J.; Glass,M. (Am J Respir Crit Care Med, 1994)